DOI: 10.1016/s1474-4422(11)70073-4. A double-blind, delayed-start trial of rasagiline in Parkinson's disease (the ADAGIO study): prespecified and post-hoc analyses of the need for additional therapies, changes in UPDRS scores, and non-motor outcomes

A double-blind, delayed-start trial of rasagiline in Parkinson's disease (the ADAGIO study): prespecified and post-hoc analyses of the need for additional therapies, changes in UPDRS scores, and non-motor outcomes

10.1016/s1474-4422(11)70073-4

Crossref journal-article

Elsevier BV

The Lancet Neurology (78)

Bibliography

Rascol, O., Fitzer-Attas, C. J., Hauser, R., Jankovic, J., Lang, A., Langston, J. W., Melamed, E., Poewe, W., Stocchi, F., Tolosa, E., Eyal, E., Weiss, Y. M., & Olanow, C. W. (2011). A double-blind, delayed-start trial of rasagiline in Parkinsonâs disease (the ADAGIO study): prespecified and post-hoc analyses of the need for additional therapies, changes in UPDRS scores, and non-motor outcomes. The Lancet Neurology, 10(5), 415â423.

Authors 13

Olivier Rascol (first)
Cheryl J Fitzer-Attas (additional)
Robert Hauser (additional)
Joseph Jankovic (additional)
Anthony Lang (additional)
J William Langston (additional)
Eldad Melamed (additional)
Werner Poewe (additional)
Fabrizio Stocchi (additional)
Eduardo Tolosa (additional)
Eli Eyal (additional)
Yoni M Weiss (additional)
C Warren Olanow (additional)

References 51 Referenced 183

10.1212/WNL.0b013e3181a1d44c / Neurology / The scientific and clinical basis for the treatment of Parkinson disease by Olanow (2009)
10.1097/00002093-199601031-00009 / Alzheimer Dis Assoc Disord / Observations and suggestions on antidementia drug development by Leber (1996)
10.1111/j.1527-3458.2005.tb00269.x / CNS Drug Rev / Neuroprotection by rasagiline: a new therapeutic approach to Parkinson's disease? by Blandini (2005)
10.1038/nrn1883 / Nat Rev Neurosci / The therapeutic potential of monoamine oxidase inhibitors by Youdim (2006)
10.1056/NEJMoa0809335 / N Engl J Med / A double-blind, delayed-start trial of rasagiline in Parkinson's disease by Olanow (2009)
10.1038/nrneurol.2010.2-c1 / Nat Rev Neurol / Discordant effects of rasagiline doses in Parkinson disease by Deftereos (2010)
10.1038/nrneurol.2010.2 / Nat Rev Neurol / Parkinson disease: ADAGIO trial hints that rasagiline slows disease progression by Sampaio (2010)
10.1212/WNL.0b013e3181d7d8e2 / Neurology / Rasagiline, Parkinson neuroprotection, and delayed-start trials: still no satisfaction? by Ahlskog (2010)
10.1007/s11910-010-0133-3 / Curr Neurol Neurosci Rep / Does rasagiline have a disease-modifying effect on Parkinson's disease? by Mehta (2010)
10.1038/466S13a / Nature / Slowing the decline by Williams (2010)
10.1002/mds.22438 / Mov Disord / Comparative responsiveness of Parkinson's disease scales to change over time by Schrag (2009)
10.1002/mds.22335 / Mov Disord / UPDRS activity of daily living score as a marker of Parkinson's disease progression by Harrison (2009)
10.1002/mds.22218 / Mov Disord / A randomized, double-blind, placebo-controlled, delayed start study to assess rasagiline as a disease modifying therapy in Parkinson's disease (the ADAGIO study): rationale, design, and baseline characteristics by Olanow (2008)
10.1136/jnnp.55.3.181 / J Neurol Neurosurg Psychiatry / Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases by Hughes (1992)
10.1016/j.parkreldis.2004.07.007 / Parkinsonism Relat Disord / The Parkinson fatigue scale by Brown (2005)
10.1002/mds.22340 / Mov Disord / Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results by Goetz (2008)
10.1208/s12248-009-9123-2 / AAPS J / Endpoints and analyses to discern disease-modifying drug effects in early Parkinson's disease by Bhattaram (2009)
10.1212/WNL.40.10.1529 / Neurology / Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group by Jankovic (1990)
10.1056/NEJM199301213280305 / N Engl J Med / Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease (1993)
10.1002/ana.410400116 / Ann Neurol / Effect of lazabemide on the progression of disability in early Parkinson's disease (1996)
10.1001/archneur.59.10.1541 / Arch Neurol / Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline by Shults (2002)
10.1001/archneur.61.4.561 / Arch Neurol / A controlled, randomized, delayed-start study of rasagiline in early Parkinson disease (2004)
10.1056/NEJMoa033447 / N Engl J Med / Levodopa and the progression of Parkinson's disease by Fahn (2004)
10.1212/01.wnl.0000250355.28474.8e / Neurology / A randomized clinical trial of coenzyme Q10 and GPI-1485 in early Parkinson disease (2007)
10.1001/archneur.59.12.1937 / Arch Neurol / A controlled trial of rasagiline in early Parkinson disease: the TEMPO Study (2002)
10.1002/mds.22402 / Mov Disord / Long-term outcome of early versus delayed rasagiline treatment in early Parkinson's disease by Hauser (2009)
10.1038/ncpneuro1049 / Nat Clin Pract Neurol / Can focusing on UPDRS Part II make assessments of Parkinson disease progression more efficient? by Sampaio (2009)
10.1002/mds.10473 / Mov Disord / The Unified Parkinson's Disease Rating Scale (UPDRS): status and recommendations (2003)
10.1001/archneur.61.10.1563 / Arch Neurol / Double-blind, placebo-controlled study of entacapone in levodopa-treated patients with stable Parkinson disease by Olanow (2004)
10.1212/WNL.49.3.665 / Neurology / Tolcapone in stable Parkinson's disease: efficacy and safety of long-term treatment. The Tolcapone Stable Study Group by Waters (1997)
10.1002/1531-8257(200005)15:3<497::AID-MDS1012>3.0.CO;2-4 / Mov Disord / Illness impact and adjustment to Parkinson's disease: before and after treatment with tolcapone by Welsh (2000)
10.1002/mds.10024 / Mov Disord / Placebo-associated improvements in motor function: comparison of subjective and objective sections of the UPDRS in early Parkinson's disease by Goetz (2002)
10.1002/mds.20324 / Mov Disord / Sydney Multicenter Study of Parkinson's disease: non-L-dopa-responsive problems dominate at 15 years by Hely (2005)
10.1136/jnnp.67.3.300 / J Neurol Neurosurg Psychiatry / The Sydney multicentre study of Parkinson's disease: progression and mortality at 10 years by Hely (1999)
10.1136/jnnp.66.4.431 / J Neurol Neurosurg Psychiatry / Influence of clinical and demographic variables on quality of life in patients with Parkinson's disease by Karlsen (1999)
10.1111/j.1468-1331.2008.02103.x / Eur J Neurol / Impact of fatigue on quality of life in patients with Parkinson's disease by Havlikova (2008)
10.1093/brain/114.5.2283 / Brain / Ageing and Parkinson's disease: substantia nigra regional selectivity by Fearnley (1991)
10.1001/archneur.62.3.378 / Arch Neurol / Nonlinear progression of Parkinson disease as determined by serial positron emission tomographic imaging of striatal fluorodopa F 18 activity by Hilker (2005)
10.1212/WNL.0b013e318198e0e9 / Neurology / Mechanisms compensating for dopamine loss in early Parkinson disease by Brotchie (2009)
10.1212/01.wnl.0000277648.63931.c0 / Neurology / Mixed lineage kinase inhibitor CEP-1347 fails to delay disability in early Parkinson disease (2007)
{'key': '10.1016/S1474-4422(11)70073-4_bib41', 'first-page': 'A82', 'article-title': "The REAL-PET study: slower progression in early Parkinson's disease treated with ropinirole compared with levodopa", 'volume': '58', 'author': 'Whone', 'year': '2002', 'journal-title': 'Neurology'} / Neurology / The REAL-PET study: slower progression in early Parkinson's disease treated with ropinirole compared with levodopa by Whone (2002)
10.1007/s00228-007-0427-9 / Eur J Clin Pharmacol / Disease progression, drug action and Parkinson's disease: why time cannot be ignored by Holford (2008)
10.1191/1740774505cn125oa / Clin Trials / Non-linearity of Parkinson's disease progression: implications for sample size calculations in clinical trials by Guimaraes (2005)
10.1016/j.parkreldis.2007.10.012 / Parkinsonism Relat Disord / Clinical features at first visit and rapid disease progression in Parkinson's disease by Ferguson (2008)
10.1016/j.parkreldis.2004.10.007 / Parkinsonism Relat Disord / Defining the Parkinson's disease phenotype: initial symptoms and baseline characteristics in a clinical cohort by Uitti (2005)
10.1007/s00415-008-0782-1 / J Neurol / Clinical heterogeneity in newly diagnosed Parkinson's disease by Post (2008)
10.1212/01.wnl.0000183359.50822.f2 / Neurology / Progression of motor impairment and disability in Parkinson disease: a population-based study by Alves (2005)
10.1136/jnnp.2006.103788 / J Neurol Neurosurg Psychiatry / Gender differences in Parkinson's disease by Haaxma (2007)
10.1001/archneur.1991.00530220069021 / Arch Neurol / Tremor at onset. Predictor of cognitive and motor outcome in Parkinson's disease? by Hershey (1991)
10.1111/j.1468-1331.2008.02514.x / Eur J Neurol / The effect of onset age on the clinical features of Parkinson's disease by Wickremaratchi (2009)
10.1001/archneur.58.10.1611 / Arch Neurol / Functional decline in Parkinson disease by Jankovic (2001)

Dates

Type	When
Created	14 years, 4 months ago (April 9, 2011, 12:09 a.m.)
Deposited	6 years, 9 months ago (Dec. 3, 2018, 8:23 a.m.)
Indexed	1 week, 2 days ago (Aug. 26, 2025, 3:02 a.m.)
Issued	14 years, 4 months ago (May 1, 2011)
Published	14 years, 4 months ago (May 1, 2011)
Published Print	14 years, 4 months ago (May 1, 2011)

Funders 0

None

BibTeX

@article{Rascol_2011, title={A double-blind, delayed-start trial of rasagiline in Parkinson’s disease (the ADAGIO study): prespecified and post-hoc analyses of the need for additional therapies, changes in UPDRS scores, and non-motor outcomes}, volume={10}, ISSN={1474-4422}, url={http://dx.doi.org/10.1016/s1474-4422(11)70073-4}, DOI={10.1016/s1474-4422(11)70073-4}, number={5}, journal={The Lancet Neurology}, publisher={Elsevier BV}, author={Rascol, Olivier and Fitzer-Attas, Cheryl J and Hauser, Robert and Jankovic, Joseph and Lang, Anthony and Langston, J William and Melamed, Eldad and Poewe, Werner and Stocchi, Fabrizio and Tolosa, Eduardo and Eyal, Eli and Weiss, Yoni M and Olanow, C Warren}, year={2011}, month=may, pages={415–423} }

JSON

{
  "indexed": {
    "date-parts": [
      [
        2025,
        8,
        26
      ]
    ],
    "date-time": "2025-08-26T07:02:48Z",
    "timestamp": 1756191768242
  },
  "reference-count": 51,
  "publisher": "Elsevier BV",
  "issue": "5",
  "license": [
    {
      "start": {
        "date-parts": [
          [
            2011,
            5,
            1
          ]
        ],
        "date-time": "2011-05-01T00:00:00Z",
        "timestamp": 1304208000000
      },
      "content-version": "tdm",
      "delay-in-days": 0,
      "URL": "https://www.elsevier.com/tdm/userlicense/1.0/"
    }
  ],
  "content-domain": {
    "domain": [],
    "crossmark-restriction": false
  },
  "published-print": {
    "date-parts": [
      [
        2011,
        5
      ]
    ]
  },
  "DOI": "10.1016/s1474-4422(11)70073-4",
  "type": "journal-article",
  "created": {
    "date-parts": [
      [
        2011,
        4,
        9
      ]
    ],
    "date-time": "2011-04-09T04:09:47Z",
    "timestamp": 1302322187000
  },
  "page": "415-423",
  "source": "Crossref",
  "is-referenced-by-count": 183,
  "title": "A double-blind, delayed-start trial of rasagiline in Parkinson's disease (the ADAGIO study): prespecified and post-hoc analyses of the need for additional therapies, changes in UPDRS scores, and non-motor outcomes",
  "prefix": "10.1016",
  "volume": "10",
  "author": [
    {
      "given": "Olivier",
      "family": "Rascol",
      "sequence": "first",
      "affiliation": []
    },
    {
      "given": "Cheryl J",
      "family": "Fitzer-Attas",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Robert",
      "family": "Hauser",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Joseph",
      "family": "Jankovic",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Anthony",
      "family": "Lang",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "J William",
      "family": "Langston",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Eldad",
      "family": "Melamed",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Werner",
      "family": "Poewe",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Fabrizio",
      "family": "Stocchi",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Eduardo",
      "family": "Tolosa",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Eli",
      "family": "Eyal",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Yoni M",
      "family": "Weiss",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "C Warren",
      "family": "Olanow",
      "sequence": "additional",
      "affiliation": []
    }
  ],
  "member": "78",
  "reference": [
    {
      "issue": "suppl 4",
      "key": "10.1016/S1474-4422(11)70073-4_bib1",
      "doi-asserted-by": "crossref",
      "first-page": "S1",
      "DOI": "10.1212/WNL.0b013e3181a1d44c",
      "article-title": "The scientific and clinical basis for the treatment of Parkinson disease",
      "volume": "72",
      "author": "Olanow",
      "year": "2009",
      "journal-title": "Neurology"
    },
    {
      "issue": "suppl 1",
      "key": "10.1016/S1474-4422(11)70073-4_bib2",
      "doi-asserted-by": "crossref",
      "first-page": "31",
      "DOI": "10.1097/00002093-199601031-00009",
      "article-title": "Observations and suggestions on antidementia drug development",
      "volume": "10",
      "author": "Leber",
      "year": "1996",
      "journal-title": "Alzheimer Dis Assoc Disord"
    },
    {
      "key": "10.1016/S1474-4422(11)70073-4_bib3",
      "doi-asserted-by": "crossref",
      "first-page": "183",
      "DOI": "10.1111/j.1527-3458.2005.tb00269.x",
      "article-title": "Neuroprotection by rasagiline: a new therapeutic approach to Parkinson's disease?",
      "volume": "11",
      "author": "Blandini",
      "year": "2005",
      "journal-title": "CNS Drug Rev"
    },
    {
      "key": "10.1016/S1474-4422(11)70073-4_bib4",
      "doi-asserted-by": "crossref",
      "first-page": "295",
      "DOI": "10.1038/nrn1883",
      "article-title": "The therapeutic potential of monoamine oxidase inhibitors",
      "volume": "7",
      "author": "Youdim",
      "year": "2006",
      "journal-title": "Nat Rev Neurosci"
    },
    {
      "key": "10.1016/S1474-4422(11)70073-4_bib5",
      "doi-asserted-by": "crossref",
      "first-page": "1268",
      "DOI": "10.1056/NEJMoa0809335",
      "article-title": "A double-blind, delayed-start trial of rasagiline in Parkinson's disease",
      "volume": "361",
      "author": "Olanow",
      "year": "2009",
      "journal-title": "N Engl J Med"
    },
    {
      "key": "10.1016/S1474-4422(11)70073-4_bib6",
      "doi-asserted-by": "crossref",
      "first-page": "1",
      "DOI": "10.1038/nrneurol.2010.2-c1",
      "article-title": "Discordant effects of rasagiline doses in Parkinson disease",
      "volume": "6",
      "author": "Deftereos",
      "year": "2010",
      "journal-title": "Nat Rev Neurol"
    },
    {
      "key": "10.1016/S1474-4422(11)70073-4_bib7",
      "doi-asserted-by": "crossref",
      "first-page": "126",
      "DOI": "10.1038/nrneurol.2010.2",
      "article-title": "Parkinson disease: ADAGIO trial hints that rasagiline slows disease progression",
      "volume": "6",
      "author": "Sampaio",
      "year": "2010",
      "journal-title": "Nat Rev Neurol"
    },
    {
      "key": "10.1016/S1474-4422(11)70073-4_bib8",
      "doi-asserted-by": "crossref",
      "first-page": "1143",
      "DOI": "10.1212/WNL.0b013e3181d7d8e2",
      "article-title": "Rasagiline, Parkinson neuroprotection, and delayed-start trials: still no satisfaction?",
      "volume": "74",
      "author": "Ahlskog",
      "year": "2010",
      "journal-title": "Neurology"
    },
    {
      "key": "10.1016/S1474-4422(11)70073-4_bib9",
      "doi-asserted-by": "crossref",
      "first-page": "413",
      "DOI": "10.1007/s11910-010-0133-3",
      "article-title": "Does rasagiline have a disease-modifying effect on Parkinson's disease?",
      "volume": "10",
      "author": "Mehta",
      "year": "2010",
      "journal-title": "Curr Neurol Neurosci Rep"
    },
    {
      "key": "10.1016/S1474-4422(11)70073-4_bib10",
      "doi-asserted-by": "crossref",
      "first-page": "S13",
      "DOI": "10.1038/466S13a",
      "article-title": "Slowing the decline",
      "volume": "466",
      "author": "Williams",
      "year": "2010",
      "journal-title": "Nature"
    },
    {
      "key": "10.1016/S1474-4422(11)70073-4_bib11",
      "doi-asserted-by": "crossref",
      "first-page": "813",
      "DOI": "10.1002/mds.22438",
      "article-title": "Comparative responsiveness of Parkinson's disease scales to change over time",
      "volume": "24",
      "author": "Schrag",
      "year": "2009",
      "journal-title": "Mov Disord"
    },
    {
      "key": "10.1016/S1474-4422(11)70073-4_bib12",
      "doi-asserted-by": "crossref",
      "first-page": "224",
      "DOI": "10.1002/mds.22335",
      "article-title": "UPDRS activity of daily living score as a marker of Parkinson's disease progression",
      "volume": "24",
      "author": "Harrison",
      "year": "2009",
      "journal-title": "Mov Disord"
    },
    {
      "key": "10.1016/S1474-4422(11)70073-4_bib13",
      "doi-asserted-by": "crossref",
      "first-page": "2194",
      "DOI": "10.1002/mds.22218",
      "article-title": "A randomized, double-blind, placebo-controlled, delayed start study to assess rasagiline as a disease modifying therapy in Parkinson's disease (the ADAGIO study): rationale, design, and baseline characteristics",
      "volume": "23",
      "author": "Olanow",
      "year": "2008",
      "journal-title": "Mov Disord"
    },
    {
      "key": "10.1016/S1474-4422(11)70073-4_bib14",
      "doi-asserted-by": "crossref",
      "first-page": "181",
      "DOI": "10.1136/jnnp.55.3.181",
      "article-title": "Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases",
      "volume": "55",
      "author": "Hughes",
      "year": "1992",
      "journal-title": "J Neurol Neurosurg Psychiatry"
    },
    {
      "key": "10.1016/S1474-4422(11)70073-4_bib15",
      "doi-asserted-by": "crossref",
      "first-page": "49",
      "DOI": "10.1016/j.parkreldis.2004.07.007",
      "article-title": "The Parkinson fatigue scale",
      "volume": "11",
      "author": "Brown",
      "year": "2005",
      "journal-title": "Parkinsonism Relat Disord"
    },
    {
      "key": "10.1016/S1474-4422(11)70073-4_bib16",
      "doi-asserted-by": "crossref",
      "first-page": "2129",
      "DOI": "10.1002/mds.22340",
      "article-title": "Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results",
      "volume": "23",
      "author": "Goetz",
      "year": "2008",
      "journal-title": "Mov Disord"
    },
    {
      "key": "10.1016/S1474-4422(11)70073-4_bib17",
      "doi-asserted-by": "crossref",
      "first-page": "456",
      "DOI": "10.1208/s12248-009-9123-2",
      "article-title": "Endpoints and analyses to discern disease-modifying drug effects in early Parkinson's disease",
      "volume": "11",
      "author": "Bhattaram",
      "year": "2009",
      "journal-title": "AAPS J"
    },
    {
      "key": "10.1016/S1474-4422(11)70073-4_bib18",
      "doi-asserted-by": "crossref",
      "first-page": "1529",
      "DOI": "10.1212/WNL.40.10.1529",
      "article-title": "Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group",
      "volume": "40",
      "author": "Jankovic",
      "year": "1990",
      "journal-title": "Neurology"
    },
    {
      "key": "10.1016/S1474-4422(11)70073-4_bib19",
      "doi-asserted-by": "crossref",
      "first-page": "176",
      "DOI": "10.1056/NEJM199301213280305",
      "article-title": "Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease",
      "volume": "328",
      "year": "1993",
      "journal-title": "N Engl J Med"
    },
    {
      "key": "10.1016/S1474-4422(11)70073-4_bib20",
      "doi-asserted-by": "crossref",
      "first-page": "99",
      "DOI": "10.1002/ana.410400116",
      "article-title": "Effect of lazabemide on the progression of disability in early Parkinson's disease",
      "volume": "40",
      "year": "1996",
      "journal-title": "Ann Neurol"
    },
    {
      "key": "10.1016/S1474-4422(11)70073-4_bib21",
      "doi-asserted-by": "crossref",
      "first-page": "1541",
      "DOI": "10.1001/archneur.59.10.1541",
      "article-title": "Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline",
      "volume": "59",
      "author": "Shults",
      "year": "2002",
      "journal-title": "Arch Neurol"
    },
    {
      "key": "10.1016/S1474-4422(11)70073-4_bib22",
      "doi-asserted-by": "crossref",
      "first-page": "561",
      "DOI": "10.1001/archneur.61.4.561",
      "article-title": "A controlled, randomized, delayed-start study of rasagiline in early Parkinson disease",
      "volume": "61",
      "year": "2004",
      "journal-title": "Arch Neurol"
    },
    {
      "key": "10.1016/S1474-4422(11)70073-4_bib23",
      "doi-asserted-by": "crossref",
      "first-page": "2498",
      "DOI": "10.1056/NEJMoa033447",
      "article-title": "Levodopa and the progression of Parkinson's disease",
      "volume": "351",
      "author": "Fahn",
      "year": "2004",
      "journal-title": "N Engl J Med"
    },
    {
      "key": "10.1016/S1474-4422(11)70073-4_bib24",
      "doi-asserted-by": "crossref",
      "first-page": "20",
      "DOI": "10.1212/01.wnl.0000250355.28474.8e",
      "article-title": "A randomized clinical trial of coenzyme Q10 and GPI-1485 in early Parkinson disease",
      "volume": "68",
      "year": "2007",
      "journal-title": "Neurology"
    },
    {
      "key": "10.1016/S1474-4422(11)70073-4_bib25",
      "doi-asserted-by": "crossref",
      "first-page": "1937",
      "DOI": "10.1001/archneur.59.12.1937",
      "article-title": "A controlled trial of rasagiline in early Parkinson disease: the TEMPO Study",
      "volume": "59",
      "year": "2002",
      "journal-title": "Arch Neurol"
    },
    {
      "key": "10.1016/S1474-4422(11)70073-4_bib26",
      "doi-asserted-by": "crossref",
      "first-page": "564",
      "DOI": "10.1002/mds.22402",
      "article-title": "Long-term outcome of early versus delayed rasagiline treatment in early Parkinson's disease",
      "volume": "24",
      "author": "Hauser",
      "year": "2009",
      "journal-title": "Mov Disord"
    },
    {
      "key": "10.1016/S1474-4422(11)70073-4_bib27",
      "doi-asserted-by": "crossref",
      "first-page": "130",
      "DOI": "10.1038/ncpneuro1049",
      "article-title": "Can focusing on UPDRS Part II make assessments of Parkinson disease progression more efficient?",
      "volume": "5",
      "author": "Sampaio",
      "year": "2009",
      "journal-title": "Nat Clin Pract Neurol"
    },
    {
      "key": "10.1016/S1474-4422(11)70073-4_bib28",
      "doi-asserted-by": "crossref",
      "first-page": "738",
      "DOI": "10.1002/mds.10473",
      "article-title": "The Unified Parkinson's Disease Rating Scale (UPDRS): status and recommendations",
      "volume": "18",
      "year": "2003",
      "journal-title": "Mov Disord"
    },
    {
      "key": "10.1016/S1474-4422(11)70073-4_bib29",
      "doi-asserted-by": "crossref",
      "first-page": "1563",
      "DOI": "10.1001/archneur.61.10.1563",
      "article-title": "Double-blind, placebo-controlled study of entacapone in levodopa-treated patients with stable Parkinson disease",
      "volume": "61",
      "author": "Olanow",
      "year": "2004",
      "journal-title": "Arch Neurol"
    },
    {
      "key": "10.1016/S1474-4422(11)70073-4_bib30",
      "doi-asserted-by": "crossref",
      "first-page": "665",
      "DOI": "10.1212/WNL.49.3.665",
      "article-title": "Tolcapone in stable Parkinson's disease: efficacy and safety of long-term treatment. The Tolcapone Stable Study Group",
      "volume": "49",
      "author": "Waters",
      "year": "1997",
      "journal-title": "Neurology"
    },
    {
      "key": "10.1016/S1474-4422(11)70073-4_bib31",
      "doi-asserted-by": "crossref",
      "first-page": "497",
      "DOI": "10.1002/1531-8257(200005)15:3<497::AID-MDS1012>3.0.CO;2-4",
      "article-title": "Illness impact and adjustment to Parkinson's disease: before and after treatment with tolcapone",
      "volume": "15",
      "author": "Welsh",
      "year": "2000",
      "journal-title": "Mov Disord"
    },
    {
      "key": "10.1016/S1474-4422(11)70073-4_bib32",
      "doi-asserted-by": "crossref",
      "first-page": "283",
      "DOI": "10.1002/mds.10024",
      "article-title": "Placebo-associated improvements in motor function: comparison of subjective and objective sections of the UPDRS in early Parkinson's disease",
      "volume": "17",
      "author": "Goetz",
      "year": "2002",
      "journal-title": "Mov Disord"
    },
    {
      "key": "10.1016/S1474-4422(11)70073-4_bib33",
      "doi-asserted-by": "crossref",
      "first-page": "190",
      "DOI": "10.1002/mds.20324",
      "article-title": "Sydney Multicenter Study of Parkinson's disease: non-L-dopa-responsive problems dominate at 15 years",
      "volume": "20",
      "author": "Hely",
      "year": "2005",
      "journal-title": "Mov Disord"
    },
    {
      "key": "10.1016/S1474-4422(11)70073-4_bib34",
      "doi-asserted-by": "crossref",
      "first-page": "300",
      "DOI": "10.1136/jnnp.67.3.300",
      "article-title": "The Sydney multicentre study of Parkinson's disease: progression and mortality at 10 years",
      "volume": "67",
      "author": "Hely",
      "year": "1999",
      "journal-title": "J Neurol Neurosurg Psychiatry"
    },
    {
      "key": "10.1016/S1474-4422(11)70073-4_bib35",
      "doi-asserted-by": "crossref",
      "first-page": "431",
      "DOI": "10.1136/jnnp.66.4.431",
      "article-title": "Influence of clinical and demographic variables on quality of life in patients with Parkinson's disease",
      "volume": "66",
      "author": "Karlsen",
      "year": "1999",
      "journal-title": "J Neurol Neurosurg Psychiatry"
    },
    {
      "key": "10.1016/S1474-4422(11)70073-4_bib36",
      "doi-asserted-by": "crossref",
      "first-page": "475",
      "DOI": "10.1111/j.1468-1331.2008.02103.x",
      "article-title": "Impact of fatigue on quality of life in patients with Parkinson's disease",
      "volume": "15",
      "author": "Havlikova",
      "year": "2008",
      "journal-title": "Eur J Neurol"
    },
    {
      "key": "10.1016/S1474-4422(11)70073-4_bib37",
      "doi-asserted-by": "crossref",
      "first-page": "2283",
      "DOI": "10.1093/brain/114.5.2283",
      "article-title": "Ageing and Parkinson's disease: substantia nigra regional selectivity",
      "volume": "114",
      "author": "Fearnley",
      "year": "1991",
      "journal-title": "Brain"
    },
    {
      "key": "10.1016/S1474-4422(11)70073-4_bib38",
      "doi-asserted-by": "crossref",
      "first-page": "378",
      "DOI": "10.1001/archneur.62.3.378",
      "article-title": "Nonlinear progression of Parkinson disease as determined by serial positron emission tomographic imaging of striatal fluorodopa F 18 activity",
      "volume": "62",
      "author": "Hilker",
      "year": "2005",
      "journal-title": "Arch Neurol"
    },
    {
      "issue": "suppl",
      "key": "10.1016/S1474-4422(11)70073-4_bib39",
      "doi-asserted-by": "crossref",
      "first-page": "S32",
      "DOI": "10.1212/WNL.0b013e318198e0e9",
      "article-title": "Mechanisms compensating for dopamine loss in early Parkinson disease",
      "volume": "72",
      "author": "Brotchie",
      "year": "2009",
      "journal-title": "Neurology"
    },
    {
      "key": "10.1016/S1474-4422(11)70073-4_bib40",
      "doi-asserted-by": "crossref",
      "first-page": "1480",
      "DOI": "10.1212/01.wnl.0000277648.63931.c0",
      "article-title": "Mixed lineage kinase inhibitor CEP-1347 fails to delay disability in early Parkinson disease",
      "volume": "69",
      "year": "2007",
      "journal-title": "Neurology"
    },
    {
      "key": "10.1016/S1474-4422(11)70073-4_bib41",
      "first-page": "A82",
      "article-title": "The REAL-PET study: slower progression in early Parkinson's disease treated with ropinirole compared with levodopa",
      "volume": "58",
      "author": "Whone",
      "year": "2002",
      "journal-title": "Neurology"
    },
    {
      "key": "10.1016/S1474-4422(11)70073-4_bib42",
      "doi-asserted-by": "crossref",
      "first-page": "207",
      "DOI": "10.1007/s00228-007-0427-9",
      "article-title": "Disease progression, drug action and Parkinson's disease: why time cannot be ignored",
      "volume": "64",
      "author": "Holford",
      "year": "2008",
      "journal-title": "Eur J Clin Pharmacol"
    },
    {
      "key": "10.1016/S1474-4422(11)70073-4_bib43",
      "doi-asserted-by": "crossref",
      "first-page": "509",
      "DOI": "10.1191/1740774505cn125oa",
      "article-title": "Non-linearity of Parkinson's disease progression: implications for sample size calculations in clinical trials",
      "volume": "2",
      "author": "Guimaraes",
      "year": "2005",
      "journal-title": "Clin Trials"
    },
    {
      "key": "10.1016/S1474-4422(11)70073-4_bib44",
      "doi-asserted-by": "crossref",
      "first-page": "431",
      "DOI": "10.1016/j.parkreldis.2007.10.012",
      "article-title": "Clinical features at first visit and rapid disease progression in Parkinson's disease",
      "volume": "14",
      "author": "Ferguson",
      "year": "2008",
      "journal-title": "Parkinsonism Relat Disord"
    },
    {
      "key": "10.1016/S1474-4422(11)70073-4_bib45",
      "doi-asserted-by": "crossref",
      "first-page": "139",
      "DOI": "10.1016/j.parkreldis.2004.10.007",
      "article-title": "Defining the Parkinson's disease phenotype: initial symptoms and baseline characteristics in a clinical cohort",
      "volume": "11",
      "author": "Uitti",
      "year": "2005",
      "journal-title": "Parkinsonism Relat Disord"
    },
    {
      "key": "10.1016/S1474-4422(11)70073-4_bib46",
      "doi-asserted-by": "crossref",
      "first-page": "716",
      "DOI": "10.1007/s00415-008-0782-1",
      "article-title": "Clinical heterogeneity in newly diagnosed Parkinson's disease",
      "volume": "255",
      "author": "Post",
      "year": "2008",
      "journal-title": "J Neurol"
    },
    {
      "key": "10.1016/S1474-4422(11)70073-4_bib47",
      "doi-asserted-by": "crossref",
      "first-page": "1436",
      "DOI": "10.1212/01.wnl.0000183359.50822.f2",
      "article-title": "Progression of motor impairment and disability in Parkinson disease: a population-based study",
      "volume": "65",
      "author": "Alves",
      "year": "2005",
      "journal-title": "Neurology"
    },
    {
      "key": "10.1016/S1474-4422(11)70073-4_bib48",
      "doi-asserted-by": "crossref",
      "first-page": "819",
      "DOI": "10.1136/jnnp.2006.103788",
      "article-title": "Gender differences in Parkinson's disease",
      "volume": "78",
      "author": "Haaxma",
      "year": "2007",
      "journal-title": "J Neurol Neurosurg Psychiatry"
    },
    {
      "key": "10.1016/S1474-4422(11)70073-4_bib49",
      "doi-asserted-by": "crossref",
      "first-page": "1049",
      "DOI": "10.1001/archneur.1991.00530220069021",
      "article-title": "Tremor at onset. Predictor of cognitive and motor outcome in Parkinson's disease?",
      "volume": "48",
      "author": "Hershey",
      "year": "1991",
      "journal-title": "Arch Neurol"
    },
    {
      "key": "10.1016/S1474-4422(11)70073-4_bib50",
      "doi-asserted-by": "crossref",
      "first-page": "450",
      "DOI": "10.1111/j.1468-1331.2008.02514.x",
      "article-title": "The effect of onset age on the clinical features of Parkinson's disease",
      "volume": "16",
      "author": "Wickremaratchi",
      "year": "2009",
      "journal-title": "Eur J Neurol"
    },
    {
      "key": "10.1016/S1474-4422(11)70073-4_bib51",
      "doi-asserted-by": "crossref",
      "first-page": "1611",
      "DOI": "10.1001/archneur.58.10.1611",
      "article-title": "Functional decline in Parkinson disease",
      "volume": "58",
      "author": "Jankovic",
      "year": "2001",
      "journal-title": "Arch Neurol"
    }
  ],
  "container-title": "The Lancet Neurology",
  "original-title": [],
  "language": "en",
  "link": [
    {
      "URL": "https://api.elsevier.com/content/article/PII:S1474442211700734?httpAccept=text/xml",
      "content-type": "text/xml",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://api.elsevier.com/content/article/PII:S1474442211700734?httpAccept=text/plain",
      "content-type": "text/plain",
      "content-version": "vor",
      "intended-application": "text-mining"
    }
  ],
  "deposited": {
    "date-parts": [
      [
        2018,
        12,
        3
      ]
    ],
    "date-time": "2018-12-03T13:23:27Z",
    "timestamp": 1543843407000
  },
  "score": 1,
  "resource": {
    "primary": {
      "URL": "https://linkinghub.elsevier.com/retrieve/pii/S1474442211700734"
    }
  },
  "subtitle": [],
  "short-title": [],
  "issued": {
    "date-parts": [
      [
        2011,
        5
      ]
    ]
  },
  "references-count": 51,
  "journal-issue": {
    "issue": "5",
    "published-print": {
      "date-parts": [
        [
          2011,
          5
        ]
      ]
    }
  },
  "alternative-id": [
    "S1474442211700734"
  ],
  "URL": "http://dx.doi.org/10.1016/S1474-4422(11)70073-4",
  "relation": {},
  "ISSN": [
    "1474-4422"
  ],
  "subject": [],
  "container-title-short": "The Lancet Neurology",
  "published": {
    "date-parts": [
      [
        2011,
        5
      ]
    ]
  }
}